Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKRA: Immune-Related Tumor Stroma Factors in Early Breast Cancer
NCT07407244Active, not recruiting
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Mar 2017
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in breast cancer, sponsored by Institute of Oncology Ljubljana. Primary endpoint: Pathological Complete Response. Started Mar 2017; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07407244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407244.